Ma X Q, He Y H, Pu J Y, Liang W P, Shao P P, Zhou J H, Zhang Y, Tang J H, Liu T L, Yuan H Q, Qiu L R
Department of Pediatric Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan430030, China.
Zhonghua Er Ke Za Zhi. 2024 Dec 2;62(12):1184-1190. doi: 10.3760/cma.j.cn112140-20240709-00466.
To investigate the prognosis and risk factors of IgA vasculitis nephritis (IgAVN) in children. A retrospective cohort study was conducted. Clinical data were collected from 264 children who were pathologically diagnosed with IgAVN at Department of Pediatric Nephrology, Tongji Hospital, affiliated with Tongji Medical College, Huazhong University of Science and Technology, between January 2011 and December 2017. All patients had a follow-up period of more than 3 years. Clinical characteristics, renal pathology, 3-year and 5-year prognosis were analyzed. The patients were grouped based on gender, age of onset (≤6 years, >6-9 years, and >9 years), pathological classification (≤Ⅲ and>Ⅲ),whether the prognosis was complete remission at 3 and 5 years. Independent sample -tests, ANOVA or chi-squared test were used for intergroup comparisons. Spearman correlation analysis was applied for ordinal data, and multivariate Logistic regression was used to analyze factors affecting the prognosis. Receiver operating characteristic (ROC) curve was utilized to evaluate the predictive value of these factors. Of the 264 children with IgAVN, 153 were male and 111 were female, the age of onset was 8.3 (6.7, 10.3) years, 118 patients (45%) with onset age >6-9 years accounted for the highest proportion. All patients presented with skin purpura and renal involvement, primarily manifesting as hematuria and/or proteinuria. Microscopic hematuria was observed in 253 patients (95.8%), while 246 patients (93.2%) showed proteinuria. In 256 patients (97.0%), hematuria or proteinuria urinalysis was detected within 6 months of skin purpura onset, and 243 patients (92.0%) underwent renal biopsy within 6 months of renal involvement. The most common clinical subtype in 264 IgAVN children was hematuria and proteinuria (204 cases, 77.3%), with grade Ⅲ being the predominant pathological classification (181 cases, 68.6%). Among children ≤6 years old, the 3-year complete remission rate was higher in males than in females (83.9% (26/31) 7/16, ²=8.12, =0.012). Factors independently associated with poor 5-year prognosis included time from hematuria or proteinuria urinalysis to renal biopsy >6 months, elevated serum cholesterol levels, and incomplete remission 3 years post-biopsy (=5.41, 1.39, 6.02, 95% 1.40-20.86, 1.04-1.84, 2.61-13.88, all <0.05). The serum cholesterol has a predictive value for 5-year prognosis (=0.020, AUC=0.62, 95% 0.52-0.71, Youden index=0.27, cutoff=4.37). For children with IgAVN aged≤6 years, the 3-year prognosis is better in males than in females. Time from hematuria or proteinuria urinalysis to renal biopsy >6 months, elevated serum cholesterol levels, and incomplete remission at 3 years post-biopsy may be independent risk factors for poor 5-year prognosis in children with IgAVN.
探讨儿童IgA血管炎肾病(IgAVN)的预后及危险因素。进行一项回顾性队列研究。收集了2011年1月至2017年12月在华中科技大学同济医学院附属同济医院儿科肾病科经病理诊断为IgAVN的264例儿童的临床资料。所有患者随访时间均超过3年。分析临床特征、肾脏病理、3年和5年预后情况。根据性别、发病年龄(≤6岁、>6 - 9岁、>9岁)、病理分级(≤Ⅲ级和>Ⅲ级)、3年和5年时预后是否完全缓解对患者进行分组。组间比较采用独立样本t检验、方差分析或卡方检验。对有序数据采用Spearman相关分析,采用多因素Logistic回归分析影响预后的因素。利用受试者工作特征(ROC)曲线评估这些因素的预测价值。在264例IgAVN儿童中,男性153例,女性111例,发病年龄为8.3(6.7,10.3)岁,其中118例(45%)发病年龄>6 - 9岁占比最高。所有患者均有皮肤紫癜和肾脏受累,主要表现为血尿和/或蛋白尿。253例(95.8%)患者出现镜下血尿,246例(93.2%)患者出现蛋白尿。256例(97.0%)患者在皮肤紫癜发作后6个月内尿检发现血尿或蛋白尿,243例(92.0%)患者在肾脏受累后6个月内进行了肾活检。264例IgAVN儿童中最常见的临床亚型是血尿和蛋白尿(204例,77.3%),Ⅲ级是主要的病理分级(181例,68.6%)。在≤6岁的儿童中,男性3年完全缓解率高于女性(83.9%(26/31)对7/16,χ² = 8.12,P = =0.012)。与5年预后不良独立相关的因素包括血尿或蛋白尿尿检至肾活检时间>6个月、血清胆固醇水平升高以及活检后3年未完全缓解(β = 5.41,1.39,6.02,95%CI 1.40 - 20.86,1.04 - 1.84,2.61 - 13.88,均P<0.05)。血清胆固醇对5年预后有预测价值(P = 0.020,AUC = 0.62,95%CI 0.52 - 0.71,约登指数 = 0.27,截断值 = 4.37)。对于≤6岁的IgAVN儿童,男性3年预后优于女性。血尿或蛋白尿尿检至肾活检时间>6个月、血清胆固醇水平升高以及活检后3年未完全缓解可能是IgAVN儿童5年预后不良的独立危险因素。